Impact Factor
Research Paper Piezocatalytic microneedle platform for biocompatible and antibacterial ROS therapy of infected wounds Full text PDF
Research Paper Z-Scheme interface engineering in bimetallic sulfide sonozymes to dismantle tumor antioxidant defenses for ferroptosis-driven sono-immunotherapy Full text PDF
Research Paper Bidirectional ROS cascade amplification in a TME-activatable nanoplatform for MRI-guided sono-chemodynamic cancer therapy Full text PDF
Research Paper Targeted delivery of selenomethionine by RGD-functionalized liposomes inhibits AAD progression through dual modulation of inflammation and BRD4 lactylation Full text PDF
Research Paper Continuous generation of functional human iPSC-derived NK cells in a scalable hematopoietic organoid system Full text PDF
Research Paper Therapeutic decoupling of restenosis prevention from impaired vascular healing with regenerative nanovesicle-eluting bioresorbable scaffolds Full text PDF
Issue 14; 2026
Founding Editor-in-Chief:
Prof. Xiaoyuan (Shawn) Chen, PhD
Profile
Theranostics publishes innovative research articles reflecting the fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensors, system biology and translational medicine, personalized medicine and a broad spectrum of biomedical research that can be applied to future theranostic applications.
- Theranostics is indexed by Science Citation Index (SCI) and MEDLINE. (Full index information)
- Full texts of articles in PubMed Central and Europe PMC. Abstracts in PubMed.
- (For NIH-funded researchers) Save time by submitting your paper to us - this journal is in full compliance with NIH Public Access Requirement.
Special Issue - Advanced Cell and Gene Therapy Strategies for Precision Treatment of Autoimmune Diseases. Theme issue editors: Weisheng Guo (Guangzhou Medical University), Xiaoyuan Chen (Shandong Cancer Hospital and Institute).
Background: Stent-based revascularization remains limited by the competing demands of restenosis prevention and vascular healing. Although drug-eluting stents reduce neointimal hyperplasia by suppressing vascular smooth muscle cell (VSMC) proliferation, their cytostatic mechanisms can delay re-endothelialization and compromise vascular repair. This unresolved therapeutic tradeoff underscores the need for a regenerative scaffold strategy that preserves ...